Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions.
Einarsdottir BO, Bagge RO, Bhadury J, Jespersen H, Mattsson J, Nilsson LM, Truvé K, López MD, Naredi P, Nilsson O, Stierner U, Ny L, Nilsson JA.
Einarsdottir BO, et al. Among authors: naredi p.
Oncotarget. 2014 Oct 30;5(20):9609-18. doi: 10.18632/oncotarget.2445.
Oncotarget. 2014.
PMID: 25228592
Free PMC article.